INSPIRATION Covid-19 prévention MTEV standard vs intermédiaire TR


Vaccin Covid-19 & thrombose. Opinions d'experts.TH


AOD chez la femme en âge de procréer : une revue ISTH.


VITT Ontario COVID-19 Science Advisory Table


GHFT Utilisation argatroban VITT


HTA traitement Trialists Collaboration Lancet


Shahjouei Covid-19 AVC Stroke


See vaccination Covid-19 & TV cérébrales série US JAMA


AHA Statement Obésité & maladies cardiovasculaires


Recos VITT - SFNV, SFMV GFHT, GIHP, SFAR, ANARLF, SFNR


Gendron N LA+ & MTEV Covid-19 Arthrit Rheum


ISTH VITT Algorithme Diagnostic & Thérapeutique


ISTH VITT Guidelines


Smadja D MTEV & ATE post vaccination Covid-19 données Vigibase Eur Resp J


Scully M FP4-dependent syndrome post vaccination NEJM


Thaler J VIPIT traitement case report JTH


HAS avis 2ème dose post AZ vaccin patients < 55 ans


Greinacher Thrombose thrombocytopénique post vaccination NEJM


EHP Guidance Thrombose & thrombocytopénie post vaccination BSH


Roubinian NH MTEV patients Covid non hospitalisés JAMA lettre


Page EM Covid-19 thrombose mécanismes TR


Vaccination Covid-19 et grossesse CRAT


Canadian Cardiovascular Society Guidelines Dyslipidémies


Vaccination Covid-19 & thrombose GFHT


VIPIT Document du Ontario COVID-19 Science Advisory Table

10 sur 41